Naval Daver, MD
Dr. Naval Daver is an Associate Professor in the Department of Leukemia at MD Anderson Cancer Center.
Articles by Naval Daver, MD
Drs. Winer, Daver, and Abaza discuss how the treatment of AML will evolve in the future.
Drs. Winer, Daver, and Abaza discuss the optimal treatment for older patients with AML.
Drs. Winer, Daver, and Abaza share their thoughts on the next major breakthroughs in the treatment of AML.
Drs. Winer, Daver, and Abaza share their thoughts and experiences with emavusertib in patients with AML.
Drs. Winer, Daver, and Abaza discuss the major breakthroughs in the treatment of acute myeloid leukemia.
Drs. Winer, Abaza, and Daver discuss their own treatment strategies for patients with AML.
Live in Chicago, this podcast episode features a panel discussion on unanswered questions in AML.
The crew talk about AML and MDS in this episode of The HemOnc Pulse.
Naval Daver, MD, checks in at The HemOnc Pulse to discuss AML in the elderly and the emergence of venetoclax.
According to results presented at ASH 2021, the triplet combination of magrolimab plus azacitidine and venetoclax was safe.
Dr. Daver shares results from a phase I/II study evaluating the addition of the anti-CD47 antibody magrolimab.
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.